/
/
/

Piramal Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)210.65
Volume (₹)26.83 L
High (₹)214.89
Upper Circuit252.88
Low (₹)209.60
Lower Circuit168.60
Prev Close210.74
52W High (₹)231.93
Price210.09
52W Low (₹)132.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)28044.80 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.68
Price to Book2.24
Book Value60.96
EPS (TTM)-2.36
Face Value10.00
ROE (%)-4.04

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
PPLPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1860.2+22.9 (1.25%)
1832.20
1891.50
4,47,476Cr
9614.5+239.5 (2.55%)
9312.50
9740
2,54,764Cr
4957.5+117.5 (2.43%)
4848.50
5010
1,89,423Cr
1179.1+19.1 (1.65%)
1152.10
1184.80
1,16,658Cr
1401+6.5 (0.47%)
1364.50
1405.20
1,11,484Cr
2047.6+93.6 (4.79%)
1963.80
2055.30
1,09,943Cr
2496.3+195.6 (8.50%)
2303
2502.70
1,01,712Cr
1205.8+20.8 (1.76%)
1185
1222
1,01,005Cr
1733.1-0.9 (-0.05%)
1689.30
1740
99,253Cr
2107.6+24.6 (1.18%)
2080
2135
96,031Cr
210.09+1.93 (0.93%)
207.68
216.70
28,045Cr

Key Highlights of Piramal Pharma Ltd Balance Sheet

Piramal Pharma Ltd balance sheet discloses shareholders' funds of ₹1327.16Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹1327.16Cr, and the reserves and surplus of the company is ₹6739.1Cr.

The company has its non-current liabilities with total liabilities of ₹12309.7Cr as of 2026-03-31.

The current liabilities are ₹2882.74Cr as of 2026-03-31. At the same time, current assets are ₹4514.56Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹3486.05Cr and tangible assets of ₹3035.86Cr, provided in the Piramal Pharma Ltd financial statements.